Selecteren primaire verpakkingen voor parenterale medicijnen

03 september 2018

Despite the proliferation of new drug delivery systems for parenteral products, glass vials remain the most widely used primary containers worldwide. This trend is expected to continue for several years, with global demand for glass vials projected to rise to $5.7 billion in 2024.
With glass and polymers offering advantages and limitations in different scenarios, many factors must be considered to determine the better choice. Some pros and cons are listed in this article. Commercializing new primary packaging for parenteral products tends to be time-consuming due to the complex regulatory approval procedures that must be followed to adopt a new packaging material (PharmTech, 2 juli 2018).
Klik hier om het volledige artikel te lezen.
Klik hier voor meer informatie over het NVC-project Pharmaceutical Packaging Innovation.
Klik hier voor meer informatie over de Live Online NVC E-Course Pharmaceutical Packaging.

Dit bericht is ook opgenomen in ons maandelijkse nieuwsoverzicht, de NVC Members-only Update. Heeft u vragen, neem dan contact met ons op via e-mail of bel: +31-(0)182-512411.